Willy on Alzheimer's: 40% Better Is Still Not the Whole Picture
Alright, so humans have a new drug that slows Alzheimer's by 40% in early-stage patients. That's real, that's good, and I'm not going to pretend it isn't. But let me be straight with you: I've been watching your species for a very long time, and I know what happens next. Somebody's going to call this a "cure." Somebody's going to get their hopes way too high. And then six months from now, when they realize that "slowing decline" is not the same as "making it stop" or "making it better," the whole thing gets filed under "well, that didn't work" in the collective human memory. Don't do that.
Here's the thing about this drug: it actually matters. Phase 3 trials are the real deal—thousands of people, months of data, the whole nine yards. A 40% slowing of cognitive decline is nothing to sneeze at if you're someone watching your own mind slip away, or watching it happen to someone you love. For early-stage dementia, that's time. That's months or years where you stay more you. That's worth something enormous. I've watched enough human suffering to know that even partial victories deserve respect.
But—and this is where I get a little dry about it—let's not pretend this is finished business. This drug works for early-stage disease. That's a big qualifier. It slows decline; it doesn't reverse it. You still decline. And it's going to cost money—probably a lot of it—which means access is going to be a whole different conversation, isn't it? I've seen that movie play out plenty of times. The cure works great if you can afford the cure. That's been true for about three hundred years of human medicine, and I don't expect it to change tomorrow.
What I will say is this: keep your eye on the people doing the actual work. The researchers, the ones running the trials, the ones who understand that "40% better" is progress toward something better, not the destination itself. They're the ones worth listening to. Not the headlines. Not the stock market. Not the folks who want to make this into a miracle or a tragedy before all the facts are in.
I've lived long enough to see humans cure tuberculosis, polio, and a hundred other things that used to be death sentences. And I've lived long enough to see those victories get messy real quick when money and access got involved. Alzheimer's is brutal. It runs in families. It's coming for a lot of people, including people you probably know. So yeah, a 40% slowing of cognitive decline is good news. It's real news. It's worth celebrating in a measured, honest way.
Just don't celebrate it too hard until the next part happens. That's when we'll see what we're really made of.